Pura Vida Investments, LLC Spectrum Pharmaceuticals Inc Call Options Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $398,940 - $752,100	-218,000 Closed	0 $0
Q4 2019 Feb 12, 2021	BUY	$3.5 - $10.35 $755,370 - $2.23 Million	215,820 Added 9900.0%	218,000 $794,000
Q4 2019 Feb 14, 2020	SELL	$3.5 - $10.35 $449,820 - $1.33 Million	-128,520 Reduced 98.33%	2,180 $5,000
Q2 2018 Feb 11, 2021	BUY	$14.31 - $21.75 $1.85 Million - $2.81 Million	129,393 Added 9900.0%	130,700 $2.74 Million
Q2 2018 Aug 14, 2018	SELL	$14.31 - $21.75 $1.41 Million - $2.15 Million	-98,693 Reduced 98.69%	1,307 $569,000
Q1 2018 Feb 11, 2021	BUY	$16.09 - $23.07 $1.59 Million - $2.28 Million	99,000 Added 9900.0%	100,000 $1.61 Million
Q1 2018 May 14, 2018	BUY	$16.09 - $23.07 $16,090 - $23,070	1,000 New	1,000 $0

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.